Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amneal Pharmaceuticals, Inc.

7.62
+0.45006.28%
Volume:2.89M
Turnover:21.67M
Market Cap:2.39B
PE:-181.00
High:7.64
Open:7.26
Low:7.26
Close:7.17
Loading ...

Amneal Pharmaceuticals (AMRX) Receives a Buy from Goldman Sachs

TIPRANKS
·
5 hours ago

Amneal Pharmaceuticals initiated with a Buy at Goldman Sachs

TIPRANKS
·
06 Jun

Amneal Pharmaceuticals Inc. Unveils Strategic Growth Plans and Product Pipeline Expansion in New Presentation

Reuters
·
05 Jun

Amneal Recalls Three Lots of Urinary Tract Infection Tablets

MT Newswires Live
·
05 Jun

Executive Vice President Nikita Shah Reports Disposal of Amneal Pharmaceuticals Inc. Common Shares

Reuters
·
20 May

Amneal Pharma Shares up 1.1% After US FDA Approves Co's Self-Administered Migraine Drug

THOMSON REUTERS
·
15 May

Amneal Pharmaceuticals' Brekiya Approved by FDA

MT Newswires Live
·
15 May

BUZZ-Amneal rises after US FDA greenlights self-administered migraine treatment

Reuters
·
15 May

Amneal Pharma Shares up 6.1% Premarket After US FDA Approves Co's Self-Administered Migraine Drug

THOMSON REUTERS
·
15 May

US FDA approves Amneal's migraine treatment

Reuters
·
15 May

Amneal Pharmaceuticals Inc. Receives FDA Approval for Brekiya® Autoinjector for Acute Migraine and Cluster Headache Treatment

Reuters
·
15 May

Amneal Pharmaceuticals Inc - Brekiya Autoinjector Available for Patients in H2 2025

THOMSON REUTERS
·
15 May

Amneal Receives U.S. FDA Approval for Brekiya® (Dihydroergotamine Mesylate) Injection for the Acute Treatment of Migraine and Cluster Headaches in Adults

THOMSON REUTERS
·
15 May

Piper Sandler Reaffirms Their Buy Rating on Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
14 May

Director John Kiely Reports Disposal of Common Shares of Amneal Pharmaceuticals Inc

Reuters
·
14 May

Stock Track | Amneal Pharmaceuticals Soars 5.06% on Production Expansion and Manufacturing Collaboration

Stock Track
·
09 May

Stock Track | Amneal Pharmaceuticals Soars 5.06% on Major Manufacturing Expansion Plans

Stock Track
·
09 May

Amneal and Apiject to Expand Sterile and Blow-Fill-Seal (Bfs) Capabilities for Advanced Pharmaceutical Manufacturing in the U.S.

THOMSON REUTERS
·
08 May

Amneal Pharma: New Infrastructure Is Expected to Have Capacity to Produce Approximately 250 to 300 Mln Units Annually

THOMSON REUTERS
·
08 May

Truist Financial Remains a Buy on Amneal Pharmaceuticals (AMRX)

TIPRANKS
·
05 May